Gemcitabine, Cisplatin, Nivolumab Facilitate Bladder Sparing
WEDNESDAY, Oct. 4, 2023 -- For patients with muscle-invasive bladder cancer (MIBC), treatment with gemcitabine, cisplatin, plus nivolumab facilitates bladder sparing, according to a study published online Oct. 2 in Nature Medicine.
Matthew D.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 4, 2023 Category: Pharmaceuticals Source Type: news
First red flag symptom of bladder cancer to spot - affects 80% of patients
Signs of the deadly disease can easily be mistaken for those of a UTI, a doctor warned. (Source: Daily Express - Health)
Source: Daily Express - Health - September 27, 2023 Category: Consumer Health News Source Type: news
Seagen Pops After Scoring A'Must-Win' For Its $43 Billion Pfizer Takeover
A bladder cancer treatment tied to a quartet of biopharma companies — including Pfizer (PFE) and buyout target Seagen (SGEN) — succeeded in a final-phase study on Friday, leading SGEN stock to surge. The companies added Merck's (MRK) Keytruda on top of Seagen and Astellas Pharma's (ALPMY) Padcev…#pfe #sgen #merck #seagen #astellaspharma #alpmy #isi #umerraffat #pfizer #padcev (Source: Reuters: Health)
Source: Reuters: Health - September 23, 2023 Category: Consumer Health News Source Type: news
Doctors lost a man's'likely cancerous' tumor before they could test it. Now he's suing
Jeremy Morton-Maxson was already dealing with news no one wanted to hear. At the age of just 39, he had gone to doctors after experiencing painful urinary issues, which raised red flags for the carpenter who comes from a family with a history of bladder cancer. After waiting upward of five months…#jeremymortonmaxson #uwmedicine #seattle #mortonmaxson #seattletimes #austinneff #uwmedicinenorthwest #mychart #uw #wisconsin (Source: Reuters: Health)
Source: Reuters: Health - September 14, 2023 Category: Consumer Health News Source Type: news
Thousands of cancer patients in England to be first in world to receive revolutionary seven-minute jab instead of an hour-long transfusion
The NHS said up to 3,600 people a year in England with specific types of lung, bladder, breast or liver cancer are set to benefit from the change. (Source: the Mail online | Health)
Source: the Mail online | Health - August 29, 2023 Category: Consumer Health News Source Type: news
Roche ’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes
Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenousTecentriq, including certain types of lung, bladder, breast and liver cancer, offering a faster, more convenient option to receive treatmentAdministered under the skin within approx. seven minutes,Tecentriq SC saves time for patients and helps conserve resources in healthcare systems1Evaluations by the FDA, EMA and other health authorities globally are ongoingBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Tecentriq ® SC (atezolizumab) has been approved by the Medicines and Healthcare products Reg...
Source: Roche Investor Update - August 29, 2023 Category: Pharmaceuticals Source Type: news
Roche ’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes
Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenousTecentriq, including certain types of lung, bladder, breast and liver cancer, offering a faster, more convenient option to receive treatmentAdministered under the skin within approx. seven minutes,Tecentriq SC saves time for patients and helps conserve resources in healthcare systems1Evaluations by the FDA, EMA and other health authorities globally are ongoingBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Tecentriq ® SC (atezolizumab) has been approved by the Medicines and Healthcare products Reg...
Source: Roche Media News - August 29, 2023 Category: Pharmaceuticals Source Type: news
FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer
[6-15-2011] The U.S. Food and Drug Administration (FDA) is informing the public that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 23, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Urine-Based DNA Methylation Test Can Detect Bladder Cancer
MONDAY, Aug. 21, 2023 -- A urine-based DNA methylation test can accurately detect bladder cancer in patients with hematuria, according to a study published online June 14 in The Journal of Molecular Diagnostics.
Tae Jeong Oh, from Genomictree, Inc.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 21, 2023 Category: Pharmaceuticals Source Type: news
New Treatment for Bladder Cancer Offers This Biotech a Second Chance
UroGen Pharma said it expects more data on the drug’s durability of response next year, when it hopes to submit it for FDA approval.#urogenpharma #fda (Source: Reuters: Health)
Source: Reuters: Health - August 17, 2023 Category: Consumer Health News Source Type: news
‘The Young & The Restless ’ Star Eric Braeden Reveals He’s Cancer-Free: “They Couldn’t Find A Damn Thing”
Some very good news from The Young & The Restless actor Eric Braeden. Braeden has revealed he’s cancer-free nearly four months after his bladder cancer diagnosis. Braeden, who has starred as Victor Newman on the CBS daytime soap since 1980, shared the news Sunday in a Facebook Live video. “The…#youngrestless #ericbraeden #victornewman #facebooklive #braeden #cedarssinaihospital #urolift (Source: Reuters: Health)
Source: Reuters: Health - August 14, 2023 Category: Consumer Health News Source Type: news
This Startup Wants To Fight Bladder Cancer With A Genetically Engineered Virus
CG Oncology, led by Forbes 30 Under 30 alum Arhtur Kuan, has developed a genetically engineered virus to treat bladder cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 2, 2023 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Daily Cover daily-cover Editors' Pick editors-pick Premium Content premiumcontent technology alexknappblog Source Type: news
SII manufactured BCG vaccine gets export nod to treat bladder cancer
The Serum Institute of India has been granted permission to export its BCG vaccine to Canada for the treatment of bladder cancer, following a request from the director, Prakash Kumar Singh. BCG as immunotherapy is a live freeze-dried preparation derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin) and is sold in 40mg and 80mg presentations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 24, 2023 Category: Pharmaceuticals Source Type: news
Tanzania: Can Pineapple Peel Juice Cure Bladder Cancer? Available Scientific Evidence Does Not Support Online Claims
[Africa Check] IN SHORT: Cancer can be debilitating and expensive to treat, which is why claims on social media that the cure lies in a widely available fruit could easily gain traction. But they are not backed up by science. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 21, 2023 Category: African Health Tags: East Africa Health and Medicine Tanzania Source Type: news
S2 Episode 5: Bladder Cancer SBRT: Meet Your Friendly Rad-Oncologist S2 Episode 5: Bladder Cancer SBRT: Meet Your Friendly Rad-Oncologist
Drs Cheryl Lee and Shekinah Elmore talk about how stereotactic body radiation therapy (SBRT) is being used in the treatment of oligometastatic bladder cancer — and how it ' s making a difference in patients ' lives.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 20, 2023 Category: Consumer Health News Tags: Urology InDiscussion Source Type: news
